Wow! That was fast. No sooner did I post Tom's last coments then I found this waiting in the wings.
"I don't see what you are seeing in PDLI. The ******** PE is over 600. Also a lot of insider selling. They have a good kidney antirejection drug, but so far, that is about it. Tom"
I should add that a 600 PE is frequently something we see in emerging tech companies just as they go from unprofitable money burning research operations to money making productive concerns. Many of these research compnies pay their brain trusts in shares rather than cash. You frequently see them selling shares as a way to buy houses, cars, the kids college bils, groceries, etc. But, Tom has a point. This is a respeculative venture.

 
Dr. Martin sent the following:
"I have been working since I talked to you last night, but there is an astonishing absence of any good stocks to buy. Everything is either at a high or has high insider selling, usually both. I think we are going to have a major correction within the next 30 to 45 days. If not then, then when Greenspan raises interest rates and pulls out the economic IV. The only thing I could find is a company named TRC Corporation (TRR). They give advice to companies on how to deal with EPA and OSHA shit (now THAT should be a good business). Great earnings, reasonable PE, coming off a low in Feb. New management since 98. The only thing that concerns me in the insider buying is very limited. One guy got 20000 shares on a share deal and sold them the same day, which is pretty typical. But, he also sold an additional 10000. One woman director about the same time bought about 9000 shares in two seperate buys, which might indicate that she saw something she liked and then liked it even better. These were recent buy/sells. I havent started working on Protein Design yet, but I will get on it."